These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33728267)

  • 1.
    Lertsinudom S; Sawanyawisuth K; Srisoi S; Areemit J; Hansuri N; Tawinkan N; Theeranut A; Sripanidkulchai B; Pranboon S
    J Tradit Complement Med; 2021 Mar; 11(2):90-94. PubMed ID: 33728267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Controlled Trial.
    Tuenthosarn K; Budkaew J; Sorncha N; Chumworathayi B
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):101-109. PubMed ID: 36708558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Vernonia cinerea (L.) Less. for smoking cessation: A systematic review and meta-analysis of randomized controlled trials.
    Puttarak P; Pornpanyanukul P; Meetam T; Bunditanukul K; Chaiyakunapruk N
    Complement Ther Med; 2018 Apr; 37():37-42. PubMed ID: 29609935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
    Fagerström K; Russ C; Yu CR; Yunis C; Foulds J
    Nicotine Tob Res; 2012 Dec; 14(12):1467-73. PubMed ID: 22467778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic cigarettes for smoking cessation and reduction.
    McRobbie H; Bullen C; Hartmann-Boyce J; Hajek P
    Cochrane Database Syst Rev; 2014; (12):CD010216. PubMed ID: 25515689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation.
    Singh P; Kumar R
    Lung India; 2010 Jan; 27(1):11-8. PubMed ID: 20539765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Mineral-Vitamin Treatment for Reduction in Cigarette Smoking: A Fully Blinded Randomized Placebo-Controlled Trial.
    Reihana PK; Blampied NM; Rucklidge JJ
    Nicotine Tob Res; 2019 Oct; 21(11):1496-1505. PubMed ID: 31665746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
    Berlin I; Saïd S; Spreux-Varoquaux O; Launay JM; Olivares R; Millet V; Lecrubier Y; Puech AJ
    Clin Pharmacol Ther; 1995 Oct; 58(4):444-52. PubMed ID: 7586937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial.
    Bohadana A; Freier-Dror Y; Peles V; Babai P; Izbicki G
    EClinicalMedicine; 2020 Feb; 19():100228. PubMed ID: 32055787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
    Agboola SA; Coleman T; McNeill A; Leonardi-Bee J
    Addiction; 2015 Jul; 110(7):1182-93. PubMed ID: 25846123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
    Rose JE; Behm FM
    Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.